Ubs Asset Management Americas Inc Cor Medix Inc. Put Options Transaction History
Ubs Asset Management Americas Inc
- $477 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CRMD
# of Institutions
181Shares Held
32.7MCall Options Held
867KPut Options Held
561K-
Vanguard Group Inc Valley Forge, PA4.33MShares$48.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$39.8 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.58MShares$28.9 Million0.04% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.71MShares$19.2 Million0.0% of portfolio
-
State Street Corp Boston, MA1.6MShares$17.9 Million0.0% of portfolio
About CorMedix Inc.
- Ticker CRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,208,200
- Market Cap $461M
- Description
- CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...